Low molecular weight heparin and atherosclerosis

被引：0
|
作者：
Hunt D. [1 ]
机构：
[1] Section of General Internal Medicine, Ben Taub General Hospital, Houston, TX 77030
来源：
Current Atherosclerosis Reports | 2004年 / 6卷 / 2期
关键词：
Percutaneous Coronary Intervention; Acute Coronary Syndrome; Enoxaparin; Abciximab; Unfractionated Heparin;
D O I：
10.1007/s11883-004-0103-9
中图分类号：
学科分类号：
摘要：
Low molecular weight heparin (LMWH) has dramatically impacted the treatment of venous thromboembolic disease and acute coronary syndromes. Recent studies help define the role of these agents for patients undergoing percutaneous coronary interventions and for patients treated with thrombolytic agents for ST-segment elevation myocardial infarction. Recent studies also suggest potential usefulness of LMWH for patients with peripheral vascular disease and its limits of utility in stroke. This review summarizes the evidence about the use of LMWH in these clinical situations. Copyright © 2004 by Current Science Inc.
引用
收藏
页码：140 / 147
页数：7
相关论文
共 50 条
  • [21] Low molecular weight heparin in children
    Manuela Albisetti
    Maureen Andrew
    European Journal of Pediatrics, 2002, 161 : 71 - 77
  • [22] LOW-MOLECULAR-WEIGHT HEPARIN
    HIRSH, J
    THROMBOSIS AND HAEMOSTASIS, 1993, 70 (01) : 204 - 207
  • [23] Low Molecular Weight Heparin and Birth Weight.
    Ogunleye, Oluseyi
    Chelliah, Anushka
    Jackson, Jessica
    Zecevic, Antonia
    Ho, Monique
    Egerman, Robert
    Gregg, Anthony
    Duff, Patrick
    REPRODUCTIVE SCIENCES, 2016, 23 : 307A - 308A
  • [24] Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (I): Preparation and characterization
    Chang L.-C.
    Lee H.-F.
    Yang Z.
    Yang V.C.
    AAPS PharmSci, 3 (3):
  • [25] Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (I): Preparation and characterization
    Chang, LC
    Lee, HF
    Yang, ZQ
    Yang, VC
    AAPS PHARMSCI, 2001, 3 (03): : art. no. - 17
  • [26] A LOW-MOLECULAR WEIGHT HEPARIN COMPARED WITH UNFRACTIONATED HEPARIN
    THOMAS, DP
    MERTON, RE
    THROMBOSIS RESEARCH, 1982, 28 (03) : 343 - 350
  • [27] Pharmacokinetics of Low Molecular Weight Heparin and Unfractionated Heparin in Pregnancy
    Mary H. H. Ensom
    Mary D. Stephenson
    The Journal of the Society for Gynecologic Investigation: JSGI, 2004, 11 : 377 - 383
  • [28] Analysis of parent heparin and their low molecular weight daughter heparin
    St Ange, Kalib
    Liu, Xinyue
    Lin, Lei
    Chi, Lianli
    Linhardt, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [29] Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy
    Ensom, MHH
    Stephenson, MD
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (06) : 377 - 383
  • [30] PHARMACOKINETICS OF UNFRACTIONATED HEPARIN AND OF LOW-MOLECULAR-WEIGHT HEPARIN
    BONEU, B
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 872 - 872
12345